CME’s performance has remained even more impressive over the longer term. CME stock has surged 19.7% on a YTD basis and 36.4% over the past year, significantly outpacing KCE’s 1.9% dip in 2025 ...

Overall, CME Group revenues are forecasted to touch $5.97 billion in FY2024. Additionally, CME’s adjusted net income margin is likely to improve in the year, leading to an annual GAAP EPS of $9.75.

CME Group's Financial Performance Revenue Growth: Over the 3 months period, CME Group showcased positive performance, achieving a revenue growth rate of 10.38% as of 31 March, 2025.

CME Group posts strong earnings on growing trading volumes and margins. Learn the risks, market opportunities, and why it's ...

CME Group’s stock (NASDAQ NDAQ: CME) has lost 9% YTD, while the S&P500 is down 18% over the same period. Further, its current price of $209 per share is trading 14% below its fair value of $243 ...

CME Group's stock performance has been underwhelming compared to the market, with low growth expectations and negative sentiment from institutional investors. However, there are reasons to ...

As we can see, CME Group is performing better than its sector in the calendar year. One other Finance stock that has outperformed the sector so far this year is Capital Southwest (CSWC). The stock ...

CME Group vs S&P 500 Performance Over 2007-08 Financial Crisis. CME Group stock declined from levels of around $122 in October 2007 (the pre-crisis peak) to roughly $36 in March 2009 (as the ...

CME Group Inc(NASDAQ:CME) recently announced a dividend of $1.1 per share, payable on 2023-09-27, with the ex-dividend date set for 2023-09-07. As investors look forward to this upcoming payment ...

CME’s performance has remained even more impressive over the longer term. CME stock has surged 19.7% on a YTD basis and 36.4% over the past year, significantly outpacing KCE’s 1.9% dip in 2025 ...